Morning Briefing
Summaries of health policy coverage from major news organizations
Antibodies Produced By People Who Recovered From H1N1 Offer Clues For Universal Flu Vaccine
The antibodies produced by individuals who fought off H1N1 (swine flu) infection last year may bring researchers one step closer to their quest to develop a "universal" flu vaccine, U.S. researchers said Monday, HealthDay News/Bloomberg Businessweek reports. As the researchers from Emory University and the University of Chicago report in the Jan. 10 issue of the Journal of Experimental Medicine, "people who were infected with the H1N1 virus and recovered had a special immune response, producing antibodies that protect against a wide variety of flu strains," the news service writes (1/10).
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
